Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis

BACKGROUND: Evidence for the preferred neoadjuvant therapy regimen in triple-negative breast cancer (TNBC) is not yet established. METHODS: Literature search was conducted from inception to February 12, 2022. Phase 2 and 3 randomized controlled trials (RCTs) investigating neoadjuvant therapy for TNB...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Yi, Gao, Hong-Fei, Yang, Xin, Zhu, Teng, Zheng, Xing-xing, Ji, Fei, Zhang, Liu-Lu, Yang, Ci-Qiu, Yang, Mei, Li, Jie-Qing, Cheng, Min-Yi, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587342/
https://www.ncbi.nlm.nih.gov/pubmed/36265208
http://dx.doi.org/10.1016/j.breast.2022.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587342/
https://www.ncbi.nlm.nih.gov/pubmed/36265208
http://dx.doi.org/10.1016/j.breast.2022.08.006

Ejemplares similares